Colorectal cancer screening study
Dr. Paul Limburg, a gastroenterology consultant at the Mayo Clinic, and CMO for screening at Exact Sciences, and co-author of this study discusses the results of the colorectal cancer screening study published in the Journal of Medical Screening. The study indicated high adherence to getting screened with the at-home, stool-based, multi-target DNA test. These findings point to the importance of choice in colorectal cancer (CRC) screening options, as well as the role of patient navigation programs to help with adherence, at a time when 1-in-3 individuals are not up to date on CRC screening.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Paul Limburg, a gastroenterology consultant at the Mayo Clinic, and CMO for screening at Exact Sciences, and co-author of this study discusses the results of the colorectal canc…
- Key Point: These findings point to the importance of choice in colorectal cancer (CRC) screening options, as well as the role of patient navigation programs to help with adherence, at a ti…
- Key Point: Limburg, M.D., is a consultant in the Division of Gastroenterology and Hepatology, with a joint appointment in the Division of Preventive, Occupational and Aerospace Medicine.
- Key Point: He is a professor of medicine in the College of Medicine, Mayo Clinic.
- Key Point: He is also the medical director of Mayo Clinic Global Business Solutions, medical director of the Preventive Services Clinic and principal investigator of the Cancer Prevention …
Paul J. Limburg, M.D., is a consultant in the Division of Gastroenterology and Hepatology, with a joint appointment in the Division of Preventive, Occupational and Aerospace Medicine. He is a professor of medicine in the College of Medicine, Mayo Clinic. He is also the medical director of Mayo Clinic Global Business Solutions, medical director of the Preventive Services Clinic and principal investigator of the Cancer Prevention Network.Dr. Limburg’s clinical and research interests are focused on chronic disease prevention, with specific emphasis on chemoprevention, molecular epidemiology, and early detection.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


